News
US FDA approves Bayer’s finerenone for new indication in patients with heart failure with left ventricular ejection fraction of ≥ 40%: Berlin Wednesday, July 16, 2025, 13:00 H ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback